Geron: FDA Clearance for Human Clinical Stem Cell Trials

Posted: Published on September 15th, 2011

This post was added by Dr. Richardson



Geron Receives FDA Clearance To Begin World's First Human Clinical Trial Of Embryonic Stem Cell-Based Therapy. Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes.

Read the original:
Geron: FDA Clearance for Human Clinical Stem Cell Trials

Related Posts
This entry was posted in Stem Cell Human Trials. Bookmark the permalink.

Comments are closed.